{"id":"W2978886033","doi":"10.1093/annonc/mdz407","title":"Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; CNIB","keywords":"Crizotinib; Medicine; Anaplastic lymphoma kinase; ROS1; Oncology; Internal medicine; Lung cancer; Clinical trial; Cancer; Adenocarcinoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002402171,0.00007912649,0.0003843752,0.00007826866,0.00002624965,0.00000138427,0.00008304712,0.00009544168,0.0001289683],"category_scores_gemma":[0.0002887694,0.00004537218,0.0001020963,0.0002017572,0.00008277542,0.0000419385,0.00004451527,0.0001012686,0.000009067102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004444211,"about_ca_system_score_gemma":0.0006244196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002349983,"about_ca_topic_score_gemma":0.0001176695,"domain_scores_codex":[0.9990951,0.00009082762,0.000385215,0.0001532995,0.00012492,0.0001506112],"domain_scores_gemma":[0.9990828,0.0002371585,0.0002363022,0.0002381644,0.0001645165,0.00004107919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5459845,0.02251205,0.003033226,0.0001519579,0.001256089,0.0001407259,0.0165009,0.00004341536,0.0254651,0.002125838,0.03485334,0.3479328],"study_design_scores_gemma":[0.6096282,0.1547295,0.02225461,0.0004871435,0.0005298649,0.00003913731,0.001684874,0.00003652759,0.07123021,0.0003814987,0.138799,0.0001994523],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9559624,0.00009995064,0.000001464719,0.007948956,0.0004126566,0.0009973538,0.0001399333,0.000005660567,0.03443165],"genre_scores_gemma":[0.9946508,0.00005342613,0.0001113688,0.0009599491,0.00008393044,0.00002757762,0.00003068358,0.000007661952,0.004074557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3477334,"threshold_uncertainty_score":0.1850224,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08230904271557742,"score_gpt":0.4842450247288527,"score_spread":0.4019359820132753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}